ImmunityBio COVID-19 vaccine

The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector[1] COVID-19 vaccine developed by the United States-based pharmaceutical company ImmunityBio.[2][1]

ImmunityBio
Vaccine description
TargetSARS-CoV-2
Vaccine typeViral vector
Clinical data
Trade nameshAd5
Identifiers
CAS Number
  1. ^ a b "ImmunityBio Inc: hAd5-Covid-19 – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 23 March 2021.
  2. ^ "SA's Biovac to team up with US based ImmunityBio in making its vaccine". BusinessInsider. Retrieved 23 March 2021.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.